Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening - 30/11/17

Doi : 10.1016/j.ccl.2016.08.008

Dan N. Tran, PharmD ^a,^{^{1
Present address: PO Box 5760, Eldoret 30100, Kenya.}}, Benson Njuguna, BPharm ^a,^b, Timothy Mercer, MD, MPH ^c,^{^{1
Present address: PO Box 5760, Eldoret 30100, Kenya.}}, Imran Manji, BPharm ^a,^b, Lydia Fischer, BA (Visual Communication Design) ^c, Marya Lieberman, PhD ^d, Sonak D. Pastakia, PharmD, BCPS, MPH ^a,^⁎
^a Department of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis, IN 46202, USA
^b Department of Pharmacy, Moi Teaching and Referral Hospital, PO Box 3, Eldoret 30100, Kenya
^c Department of Medicine, Indiana University School of Medicine, 1120 West Michigan Street, Indianapolis, IN 46202, USA
^d Department of Chemistry and Biochemistry, University of Notre Dame, 250 Nieuwland, Notre Dame, IN 46556, USA

^∗Corresponding author. PO Box 5760, Eldoret 30100, Kenya.PO Box 5760Eldoret30100Kenya

Résumé

Cardiovascular disease (CVD) is the leading cause of global mortality and is expected to reach 23 million deaths by 2030. Eighty percent of CVD deaths occur in low-income and middle-income countries (LMICs). Although CVD prevention and treatment guidelines are available, translating these into practice is hampered in LMICs by inadequate health care systems that limit access to lifesaving medications. In this review article, we describe the deficiencies in the current LMIC supply chains that limit access to effective CVD medicines, and discuss existing solutions that are translatable to similar settings so as to address these deficiencies.

Le texte complet de cet article est disponible en PDF.

Keywords : Patient-centered access, Cardiovascular disease medicines, Availability, Accountability, Adherence, Health-system strengthening, Low-income and middle-income countries, Falsified and substandard medicines

Plan

Disclosure Statement: The authors do not have any commercial or financial conflicts of interests, or any funding sources to declare (D.N. Tran, B. Njuguna, T. Mercer, I. Manji, L. Fischer). M. Lieberman has received funding for this project from the Bill & Melinda Gates Foundation (OPP1108078), US-AID DIV program (AID-0AA-F-15-00050), and Indiana CTSI program. S. Pastakia has previously served as a consultant for Abbott but this activity is unrelated to the work described in this article.

Export

Vol 35 - N° 1

P. 125-134 - février 2017 Retour au numéro

Article précédent

Ambulatory Blood Pressure Monitoring : A Complementary Strategy for Hypertension Diagnosis and Management in Low-Income and Middle-Income Countries
Marwah Abdalla

| Article suivant

Tuberculosis and the Heart
Arthur K. Mutyaba, Mpiko Ntsekhe

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening - 30/11/17

Résumé

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL